Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
64
NBIX Quote, Financials, Valuation and Earnings
Last price:
$134.19
Seasonality move
:
3.15%
Day range:
$131.07 - $134.25
52-week range:
$84.23 - $157.98
Dividend yield:
0%
P/E ratio:
45.25x
P/S ratio:
5.72x
P/B ratio:
5.21x
Volume:
905.5K
Avg. volume:
841.7K
1-year change:
-9.47%
Market cap:
$13.2B
Revenue:
$2.4B
EPS (TTM):
$2.95
Earnings Data
Next earnings date for NBIX
Aug 01
2025
Most recent earnings per share
$0.08
Missed by $1.01
(May 5/2025)
Consensus Estimate
$1.09
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NBIX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $717.3M | -- | -- | $1.91 | -- |
| 08/01/2025 | Q2 | $653.5M | -- | -- | $1.47 | -- |
| 05/05/2025 | Q1 | $561M | $572.6M | $0.08 | $1.09 | -$1.01 |
| 02/06/2025 | Q4 | $629.4M | $627.7M | $1.00 | $1.93 | -$0.93 |
| 10/30/2024 | Q3 | $602.8M | $622.1M | $1.24 | $1.82 | -$0.58 |
| 08/01/2024 | Q2 | $546.6M | $590.2M | $0.63 | $1.53 | -$0.90 |
| 05/01/2024 | Q1 | $512M | $515.3M | $0.42 | $1.29 | -$0.87 |
| 02/07/2024 | Q4 | $518.4M | $515.2M | $1.44 | $1.51 | -$0.07 |
| 10/31/2023 | Q3 | -- | -- | $0.82 | $1.33 | -$0.51 |
| 08/01/2023 | Q2 | -- | -- | $0.95 | $1.12 | -$0.17 |
| 05/03/2023 | Q1 | -- | -- | -$0.79 | $0.74 | -$1.53 |
| 02/06/2023 | Q4 | -- | -- | $0.88 | $1.44 | -$0.56 |
| 11/01/2022 | Q3 | -- | -- | $0.69 | $1.12 | -$0.43 |
| 08/04/2022 | Q2 | -- | -- | -$0.18 | $0.89 | -$1.07 |
| 05/04/2022 | Q1 | -- | -- | $0.14 | $0.59 | -$0.45 |
| 02/11/2022 | Q4 | -- | -- | -$0.08 | $0.88 | -$0.96 |
| 11/01/2021 | Q3 | -- | -- | $0.23 | $0.80 | -$0.57 |
| 08/03/2021 | Q2 | -- | -- | $0.43 | $0.76 | -$0.33 |
| 05/05/2021 | Q1 | -- | -- | $0.33 | $0.72 | -$0.39 |
| 02/04/2021 | Q4 | -- | -- | $3.58 | $0.90 | $2.68 |
| 11/09/2020 | Q3 | -- | -- | -$0.62 | $1.25 | -$1.87 |
| 08/03/2020 | Q2 | -- | -- | $0.81 | $1.02 | -$0.21 |
| 05/06/2020 | Q1 | -- | -- | $0.39 | $0.64 | -$0.25 |
| 02/04/2020 | Q4 | -- | -- | $0.35 | $0.75 | -$0.40 |
| 11/04/2019 | Q3 | -- | -- | $0.56 | $0.64 | -$0.08 |
| 07/29/2019 | Q2 | -- | -- | $0.54 | $0.25 | $0.29 |
| 04/29/2019 | Q1 | -- | -- | -$1.12 | -$0.89 | -$0.23 |
| 02/05/2019 | Q4 | -- | -- | $0.19 | $0.19 | -$0.00 |
| 11/05/2018 | Q3 | -- | -- | $0.52 | $0.49 | $0.03 |
| 07/31/2018 | Q2 | -- | -- | -$0.07 | -$0.18 | $0.11 |
| 04/30/2018 | Q1 | -- | -- | -$0.47 | -$0.30 | -$0.17 |
| 02/13/2018 | Q4 | -- | -- | $0.07 | $0.16 | -$0.09 |
| 11/01/2017 | Q3 | -- | -- | -$0.13 | -$0.53 | $0.40 |
| 08/03/2017 | Q2 | -- | -- | -$0.68 | -$0.65 | -$0.03 |
| 05/09/2017 | Q1 | -- | -- | -$0.90 | -$0.72 | -$0.18 |
| 02/14/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/02/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/11/2016 | Q4 | -- | -- | -- | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -- | -- | -- |
Neurocrine Biosciences Earnings Questions
-
How Much did Neurocrine Biosciences Generate in Revenue Last Quarter?
Neurocrine Biosciences reported $572.6M worth of top line sales in its most recent quarter.
-
Did Neurocrine Biosciences Beat Earnings Last Quarter?
Neurocrine Biosciences announced earnings per share of $0.08 which represents a miss of analyst forecast a $1.09 per share.
-
Is Neurocrine Biosciences Profitable?
Neurocrine Biosciences reported $563.4M that represents $5.50 per share over the last quarter.
-
What is the Analyst Consensus for Neurocrine Biosciences EPS Next Year?
Neurocrine Biosciences's earnings are forecast to grow from $3.29 per share to $6.60 per share next year representing an increase of 85.15%.
-
When is Neurocrine Biosciences's Earnings Date?
Neurocrine Biosciences's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
